SEC Company Response from NeuroSense Therapeutics (NRSN) — Nov 24, 2025
NeuroSense Therapeutics Ltd.
Date: Nov. 24, 2025 · CIK: 0001875091 · Accession: 0001213900-25-114111
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291122
Letter
NeuroSense Theapeutics Ltd.
11 HaMenofim Street, Building B
Herzliya 4672562
November 24, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: NeuroSense Therapeutics Ltd. (CIK 0001875091)
Registration Statement No. 333-291122 on Form F-3 (the "Registration Statement")
Ladies and Gentlemen:
NeuroSense Therapeutics Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on November 25, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at + 972 (0) 3.636.6033. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
NEUROSENSE THERAPEUTICS LTD.
Show Raw Text
CORRESP 1 filename1.htm NeuroSense Theapeutics Ltd. 11 HaMenofim Street, Building B Herzliya 4672562 November 24, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: NeuroSense Therapeutics Ltd. (CIK 0001875091) Registration Statement No. 333-291122 on Form F-3 (the "Registration Statement") Ladies and Gentlemen: NeuroSense Therapeutics Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on November 25, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at + 972 (0) 3.636.6033. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, NEUROSENSE THERAPEUTICS LTD. By: /s/ Or Eisenberg Or Eisenberg Chief Financial Officer